Monopar Therapeutics Inc. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable
Monopar Therapeutics Inc. (MNPR) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable of 454.41 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Option, Exercise Price Range, Beginning of Period
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions · last filed 2026-08-12
- 2026-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 454.41K shares.
- 2026-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 431.25K shares.
- 2025-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 411.33K shares.
- 2025-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 399.04K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable |
|---|---|
| 2026-06-30 | 454.41K shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 431.25K shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 411.33K shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 399.04K shares 10-Q · filed 2025-11-13 |
| 2025-06-30 | 407.72K shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 369.21K shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 339.88K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 324.49K shares 10-Q · filed 2024-11-08 |
| 2024-06-30 | 1.56M shares 10-Q · filed 2024-08-09 |
| 2024-03-31 | 1.58M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 1.51M shares 10-K · filed 2024-03-28 |
| 2023-06-30 | 1.35M shares 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |